Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

121 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Carbapenem use in extended-spectrum cephalosporin-resistant Enterobacterales infections in US hospitals and influence of IDSA guidance: a retrospective cohort study.
Walker MK, Diao G, Warner S, Babiker A, Neupane M, Strich JR, Yek C, Kadri SS; National Institutes of Health Antimicrobial Resistance Outcomes Research Initiative (NIH–ARORI). Walker MK, et al. Among authors: kadri ss. Lancet Infect Dis. 2024 Aug;24(8):856-867. doi: 10.1016/S1473-3099(24)00149-X. Epub 2024 Apr 25. Lancet Infect Dis. 2024. PMID: 38679036
Difficult-to-Treat Resistance in Gram-negative Bacteremia at 173 US Hospitals: Retrospective Cohort Analysis of Prevalence, Predictors, and Outcome of Resistance to All First-line Agents.
Kadri SS, Adjemian J, Lai YL, Spaulding AB, Ricotta E, Prevots DR, Palmore TN, Rhee C, Klompas M, Dekker JP, Powers JH 3rd, Suffredini AF, Hooper DC, Fridkin S, Danner RL; National Institutes of Health Antimicrobial Resistance Outcomes Research Initiative (NIH–ARORI). Kadri SS, et al. Clin Infect Dis. 2018 Nov 28;67(12):1803-1814. doi: 10.1093/cid/ciy378. Clin Infect Dis. 2018. PMID: 30052813 Free PMC article.
Attributable mortality from extensively drug-resistant gram-negative infections using propensity-matched tracer antibiotic algorithms.
Kadri SS, Strich JR, Swihart BJ, Hohmann S, Dekker JP, Palmore T, Bonne S, Freeman B, Raybould J, Shah NG, Patel D, Husson J, Jacobs MD, Duong L, Follmann D, Hooper DC, Timpone J, Danner RL. Kadri SS, et al. Am J Infect Control. 2019 Sep;47(9):1040-1047. doi: 10.1016/j.ajic.2019.01.010. Epub 2019 Feb 27. Am J Infect Control. 2019. PMID: 30824387 Free PMC article.
External Validation of Difficult-to-Treat Resistance Prevalence and Mortality Risk in Gram-Negative Bloodstream Infection Using Electronic Health Record Data From 140 US Hospitals.
Kadri SS, Lai YLE, Ricotta EE, Strich JR, Babiker A, Rhee C, Klompas M, Dekker JP, Powers JH 3rd, Danner RL, Adjemian J; NIH Antimicrobial Resistance Outcomes Research Initiative (NIH-ARORI). Kadri SS, et al. Open Forum Infect Dis. 2019 Feb 28;6(4):ofz110. doi: 10.1093/ofid/ofz110. eCollection 2019 Apr. Open Forum Infect Dis. 2019. PMID: 31240236 Free PMC article.
121 results